Get the Stockscreener App
0.1067
7.67%
0.0076
After Hours:
.10
-0.0067
-6.28%
Conduit Pharmaceuticals Inc Stock (CDT) Latest News
Conduit Pharmaceuticals issues convertible note, amends Nirland agreement - Investing.com
What's Going On With Conduit Pharmaceuticals Shares Today? - Benzinga
Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - The Manila Times
Conduit Pharmaceuticals receives further patent approval for AZD1656 - TipRanks
Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market | CDT Stock News - StockTitan
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve
Conduit Pharmaceuticals reshuffles board and amends bylaws - Investing.com
Conduit Pharmaceuticals reshuffles board and amends bylaws By Investing.com - Investing.com UK
Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update - TipRanks
Conduit Pharmaceuticals Strengthens Board with 30-Year Investment Banking Veteran Simon Fry | CDT Stock News - StockTitan
Conduit Pharmaceuticals announces restatement of financials - Investing.com
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
Remitly Global Inc (NASDAQ: RELY) Is The Number One Stock Currently Moving. - Stocks Register
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Conduit Pharmaceuticals announces new addition to autoimmune pipeline - Yahoo Finance
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - StockTitan
Conduit Pharmaceuticals Opens New Lab Space In Cambridge, UK - Contract Pharma
Conduit Pharmaceuticals secures $1.2 million in funding - Investing.com India
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - The Manila Times
Conduit Pharmaceuticals secures $1.2 million in funding By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals announces debt restructuring and additional notes - MSN
LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times
Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements - TipRanks
Lexicon Pharmaceuticals Loses Over A Third Of Its Market Cap Post FDA Vote On Drug: Retail Sentiment Sours - MSN
Prologis Inc (NYSE: PLD): Forecast Strong In 2024, Up 18.49% - Stocks Register
Where Do Analysts Think The Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Going - Stocks Register
Presidio Property Trust Provides Update on Model Home Activity in Q3 2024 - The Manila Times
Conduit Pharmaceuticals announces debt restructuring By Investing.com - Investing.com Australia
Conduit Pharmaceuticals announces debt restructuring - Investing.com India
CDT Stock on the Rise: A Promising Investment - The InvestChronicle
Conduit Pharmaceuticals Inc [CDT] Insider Nirland Ltd sells 1,500,000 Shares – Insider Selling Alert - Knox Daily
Investing in Capricor Therapeutics Inc (CAPR): What You Must Know - Knox Daily
A stock that deserves closer examination: Conduit Pharmaceuticals Inc (CDT) - US Post News
CDT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Selling Buzz: Conduit Pharmaceuticals Inc [CDT] 10% Owner Nirland Ltd sells 1,500,000 shares of the company - Knox Daily
Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7SEC Filing - XM
There is no way Conduit Pharmaceuticals Inc (CDT) can keep these numbers up - SETE News
Conduit Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Ltd Nirland Sells 939,009 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Stock - Defense World
Conduit Pharmaceuticals insiders sell shares worth over $393k By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals insiders sell shares worth over $393k - Investing.com
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 9.50M – now what? - The DBT News
Examining Conduit Pharmaceuticals Inc (CDT) more closely is necessary - US Post News
Balance Sheet Dive: Conduit Pharmaceuticals Inc (CDT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Conduit Pharmaceuticals Inc [CDT] Records 50-Day SMA of $0.1531 - Knox Daily
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Conduit Pharmaceuticals executives sell shares worth over $297k By Investing.com - Investing.com Canada
Conduit Pharmaceuticals executives sell shares worth over $297k - Investing.com
Insider Selling: Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Major Shareholder Sells 1,016,823 Shares of Stock - Defense World
Conduit Pharmaceuticals Inc (CDT) expanding its growth trajectory ahead - SETE News
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 10.18M – now what? - The DBT News
Conduit Pharmaceuticals Inc [CDT] Insider Regan Andrew sells 10,244,392 Shares – Insider Selling Alert - Knox Daily
CDT stock plunges to 52-week low, touches $0.11 amid market challenges - Investing.com Canada
Presidio Property Trust Announces Series D Preferred Stock Cash Dividend - The Manila Times
In the Green: Conduit Pharmaceuticals Inc (CDT) Closes at 0.13, Up/Down -2.64 from Previous Day - The Dwinnex
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):